Clinical Trial Update: IVIG vs SCIG in CIDP [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial comparing intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) for chronic inflammatory demyelinating polyneuropath…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunoglobulin Deficiency
• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)
• Subcutaneous Immunoglobulin (SCIG) (immunoglobulin G (IgG))

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: CIDP, Immunoglobulin Deficiency | Phase 1 | Status: RECRUITING